Revvity: Leerink Partners raises target price to $160 from $145
RVTY•Leerink Partners raised its target price for Revvity to $160 from $145.
Related News
TD Synnex Q3 adjusted EPS eases past estimates on strong Distribution and Hyve performance
SNX•
Paychex, Inc.: UBS cuts target price to $115 from $125
PAYX•
Leerink sees life-science tools benefiting from Anthropic's push into biology
TWST•
Acadia falls after Alzheimer's-related drug narrowly misses goal in study
ACAD•
Frontier Group Holdings: UBS cuts target price to $6 from $7
ULCC•